Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Edith Julia | Researchclopedia

Back to researchers

Edith Julia

Université Claude Bernard Lyon 1 ORCID

26

Works

101

Citations

4

h-index

1

i10-index

Research Topics

Lymphoma Diagnosis and Treatment CAR-T cell therapy research Cutaneous lymphoproliferative disorders research

Affiliations

Université Claude Bernard Lyon 12021–2026

École Normale Supérieure de Lyon2024–2026

Centre National de la Recherche Scientifique2021–2026

Inserm2021–2026

Lyon College2025–2025

Top Works

Ezh2 Inhibition by Tazemetostat: Mechanisms of Action, Safety and Efficacy in Relapsed/refractory Follicular Lymphoma

Edith Julia,Gilles Salles

202168 citations

T-cell and Retrovirus Studies

CNS Lymphoma Diagnosis and Treatment

Massive haemoptysis complicating exogenous lipid pneumonia

Manuel Larrosa Haro,I Murcia,et al.

19989 citations

Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming

Sylvain Carras,Dimitri Chartoire,et al.

20216 citations

Validation of the PRIMA-Prognostic Index for Patients Treated with Rituximab Plus Chemotherapy and Refinement of Prognostic Parameters for Patients on Rituximab Plus Lenalidomide in the Phase III Relevance Trial

Edith Julia,Nathan Fowler,et al.

20194 citations

Functional precision oncology for follicular lymphoma with patient-derived xenograft in avian embryos

Manon Zala,Boris Lipinski,et al.

20244 citations

Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery

Aleksandr Ianevski,Kristen Nader,et al.

20252 citations

Skeletal Muscle Index, As a Measure of Muscle Mass, Is a Significant Prognostic Factor for Newly Diagnosed Diffuse Large B-Cell Primary CNS Lymphoma Patients

Gabriel Antherieu,Edith Julia,et al.

20231 citations

Diagnosis-to-Treatment Interval Is an Important Prognostic Factor with a Time-Dependent Effect Predicting Event-Free Survival after 12 Months from First-Line Treatment in Newly Diagnosed Diffuse Large B-Cell Primary CNS Lymphoma

Marie‐Charlotte Laude,Edith Julia,et al.

20201 citations

Distinct Molecular Aberrations of Classic Hodgkin Lymphoma in Older Adults Identified By Comprehensive Genomic Profiling

Cédric Rossi,Jan Boegeholz,et al.

20241 citations